Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
The Pharmacogenomics Journal|May 3, 2019
Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn's diseaseAdrià Aterido, Núria Palau, Eugeni Domènech, et al.Journal of Crohn'S & Colitis|March 24, 2020
Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA RegistryMargalida Calafat, Míriam Mañosa, Francisco Mesonero, et al.Alimentary Pharmacology & Therapeutics|August 21, 2019
Increased risk of thiopurine-related adverse events in elderly patients with IBDMargalida Calafat, Míriam Mañosa, Fiorella Cañete, et al.Human Molecular Genetics|August 2, 2014
A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitisAntonio Julià, Eugeni Domènech, María Chaparro, et al.Journal of Crohn'S & Colitis|November 19, 2025
Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCUJordina Llaó, Míriam Mañosa, Eduardo Martín-Arranz, et al.Gut|September 1, 2012
A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300Antonio Julià, Eugeni Domènech, Elena Ricart, et al.Gastroenterology|January 6, 2015
Identification of risk loci for Crohn's disease phenotypes using a genome-wide association studyArnald Alonso, Eugeni Domènech, Antonio Julià, et al.Journal of Crohn'S & Colitis|December 5, 2021
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA RegistryMargalida Calafat, Míriam Mañosa, Elena Ricart, et al.Journal of Clinical Medicine|July 9, 2022
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCUSabino Riestra, Carlos Taxonera, Yamile Zabana, et al.Postgraduate Medical Journal|June 24, 2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA projectCarlos González-Muñoza, Margalida Calafat, Javier P Gisbert, et al.Pageof 7